Insider · CIK 0002148571
Robert William Gunning
officer
Files at NAMS (NewAmsterdam Pharma Co N.V.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Ordinary Shares | +3,200 | $0.00 | $0 | 3,200 | 39 d ago |
| Sep 1, 2026 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | 39 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.